Lacosamide
- Product NDC
- 42291-863
- 11-digit product format
- 422910863
- Labeler code
- 42291
- Product ID
- 42291-863_e18102d6-764b-0a82-e053-2a95a90a85e0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lacosamide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA204857
- Marketing category
- ANDA
- Marketing start
- 2022-06-15
- Marketing end
- 0000-00-00
- Substance
- LACOSAMIDE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- DEA schedule
- CV
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-863-60 | 42291086360 | 60 TABLET in 1 BOTTLE (42291-863-60) | 60 tablet | 2022-06-15 | 0000-00-00 | No | No | Current |